GB0517466D0 - Diagnostic assay and therapeutic treatment - Google Patents

Diagnostic assay and therapeutic treatment

Info

Publication number
GB0517466D0
GB0517466D0 GB0517466A GB0517466A GB0517466D0 GB 0517466 D0 GB0517466 D0 GB 0517466D0 GB 0517466 A GB0517466 A GB 0517466A GB 0517466 A GB0517466 A GB 0517466A GB 0517466 D0 GB0517466 D0 GB 0517466D0
Authority
GB
United Kingdom
Prior art keywords
diagnostic assay
therapeutic treatment
treatment
mir
bone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0517466A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunodiagnostic Systems Ltd
Original Assignee
Immunodiagnostic Systems Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunodiagnostic Systems Ltd filed Critical Immunodiagnostic Systems Ltd
Priority to GB0517466A priority Critical patent/GB0517466D0/en
Publication of GB0517466D0 publication Critical patent/GB0517466D0/en
Priority to PCT/GB2006/003204 priority patent/WO2007023306A1/en
Ceased legal-status Critical Current

Links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

We disclose a diagnostic assay to determine whether a subject has developed, is likely to develop, or is responding to treatment of, a bone disorder, typically osteoporosis, by determining the expression of micro RWA mir-223 or of two gene markers localised with mir-223 on the same gene locus or chromosome X. Pharmaceutical compositions comprising nucleic acids or polypeptides useful in the treatment of said bone disorders are also disclosed.
GB0517466A 2005-08-26 2005-08-26 Diagnostic assay and therapeutic treatment Ceased GB0517466D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0517466A GB0517466D0 (en) 2005-08-26 2005-08-26 Diagnostic assay and therapeutic treatment
PCT/GB2006/003204 WO2007023306A1 (en) 2005-08-26 2006-08-25 Diagnostic assay and therapeutic treatment for bone disorders (osteoporosis)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0517466A GB0517466D0 (en) 2005-08-26 2005-08-26 Diagnostic assay and therapeutic treatment

Publications (1)

Publication Number Publication Date
GB0517466D0 true GB0517466D0 (en) 2005-10-05

Family

ID=35198445

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0517466A Ceased GB0517466D0 (en) 2005-08-26 2005-08-26 Diagnostic assay and therapeutic treatment

Country Status (2)

Country Link
GB (1) GB0517466D0 (en)
WO (1) WO2007023306A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2288126B2 (en) * 2006-06-01 2009-07-06 Universitat De Les Illes Balears USE OF FITATE AS AN INHIBITING AGENT FOR THE DISSOLUTION OF CRYSTALS OF SALES CALCICAS FOR THE PREVENTION OR TREATMENT OF OSTEOPOROSIS.
JP6841661B2 (en) * 2014-06-13 2021-03-10 ウニヴェルズィテート・フューア・ボーデンクルトゥーア・ウィーン Compositions and Methods for Diagnosis and Treatment of Fractures and Bone Disorders
WO2017098052A1 (en) * 2015-12-10 2017-06-15 Universität Für Bodenkultur Wien Compositions and methods for the diagnosis and treatment of bone fractures and disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999007891A1 (en) * 1997-08-05 1999-02-18 Human Genome Sciences, Inc. 90 human secreted proteins
AUPP547398A0 (en) * 1998-08-26 1998-09-17 Medvet Science Pty. Ltd. Predictive assessment of certain skeletal disorders
DE10127572A1 (en) * 2001-05-30 2002-12-05 Pathoarray Gmbh Tools for the diagnosis, molecular definition and therapy development of chronic inflammatory joint diseases
EP1419265A2 (en) * 2001-08-03 2004-05-19 Gene Logic, Inc. Gene associated with bone disorders
EP1556490A4 (en) * 2002-10-22 2006-04-05 Nuvelo Inc Novel nucleic acids and polypeptides
WO2005047505A2 (en) * 2003-08-07 2005-05-26 Whitehead Institute For Biomedical Research Methods and products for expression of micro rnas
EP2295604B1 (en) * 2004-02-09 2015-04-08 Thomas Jefferson University Diagnosis and treatment of cancers with microRNA located in or near cancer-associated chromosomal features

Also Published As

Publication number Publication date
WO2007023306A1 (en) 2007-03-01

Similar Documents

Publication Publication Date Title
BRPI0507960A (en) therapeutic methods employing nitric oxide precursors
WO2004066941A3 (en) Expression profiles for colon cancer and methods of use
WO2008151803A3 (en) New polymorphisms in abcb1 associated with a lack of clinical response to medicaments
WO2007058968A3 (en) Gene expression profiles and methods of use
WO2005100998A3 (en) Membrane markers for use in cancer diagnosis and therapy
WO2009059318A3 (en) Genes and polymorphisms associated with amd
EP2438962A3 (en) Polynucleotides and polypeptide sequences involved in the process of bone remodeling
WO2005067391A3 (en) Diagnostic test for parkinson's disease
WO2009137660A3 (en) Enhancement of drug therapy by mirna
WO2007133682A3 (en) 100% sequence identity detection methods for variable genomes
ATE526975T1 (en) PKR ACTIVATION USING HYBRIDIZATION CHAIN REACTION
WO2008146309A3 (en) Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
BRPI0819193A2 (en) use of modified base oligonucleotides in nucleic acid hybridization.
WO2005032495A8 (en) Gene expression profiles and methods of use
WO2008093165A3 (en) The use of pgil ohgosaccharyltransferase for o-glycosylating proteins
WO2010011283A3 (en) Fus/tls-based compounds and methods for diagnosis, treatment and prevention of amyotrophic lateral sclerosis and related motor neuron diseases
BRPI0520067A2 (en) development of a real time pcr assay for pneumococcal DNA detection and diagnosis of pneumococcal disease
WO2008088860A3 (en) Polymorphisms in the egfr pathway as markers for cancer treatment
BRPI0816047A2 (en) oligonucleotide array for detection of a target nucleic acid, methods for detecting the presence or absence of a target nucleic acid and at least two target nucleic acids, kit, reaction mixture and fluorescence-identified amplicon
WO2007109733A3 (en) Diagnostic and prognostic markers and treatment strategies for multiple sclerosis
WO2012056451A3 (en) Peripheral blood gene markers for early diagnosis of parkinson's disease
GB0517466D0 (en) Diagnostic assay and therapeutic treatment
WO2006122971A3 (en) Treatment of disease using an improved regulated expression system
MXPA05006034A (en) Replication protein.
MX2016012718A (en) Determination of single nucleotide polymorphisms useful to predict response for rasagiline.

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)